Published on 19 Apr 2023 on Simply Wall St. via Yahoo Finance
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shareholders won't be pleased to see that the share price has had a very rough month, dropping 52% and undoing the prior period's positive performance. For any long-term shareholders, the last month ends a year to forget by locking in a 90% share price decline.
Following the heavy fall in price, ThermoGenesis Holdings may look like a strong buying opportunity at present with its price-to-sales (or "P/S") ratio of 0.4x, considering almost half of all companies in the Medical Equipment industry in the United States have P/S ratios greater than 3.5x and even P/S higher than 8x aren't out of the ordinary. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.
View our latest analysis for ThermoGenesis Holdings